BPC-157 for sale: what is actually on the market
BPC-157 for sale is not one product. Search the term and you get lyophilized vials, blends with three or four peptides in them, pre-filled syringes of clear liquid, oral capsules and nasal sprays, all priced per unit in ways that cannot be compared. Since there is no approved BPC-157 medicine anywhere in the world, no regulator has ever defined what a legitimate presentation of it looks like, so the market defined it instead. This article sorts the formats.
The compound is fixed even when the packaging is not. BPC-157 is a synthetic pentadecapeptide, fifteen amino acids, formula C62H98N16O22, molecular weight around 1419.5, based on a fragment of a protein found in human gastric juice. Its reputation rests on rat and cell studies of tendon, ligament and gut healing, much of that work from a single group in Zagreb, with no completed large human efficacy trial. You can see the published record on PubMed. One controlled human trial is now running, NCT07437547, a Phase 2 study of BPC 157 in acute hamstring muscle strain sponsored by Hudson Biotech, which started on 2 February 2026 with 120 participants and is not due to reach primary completion before 14 February 2027. It has reported nothing, so no format on this page is backed by a human result.
Anyone searching bpc-157 peptide for sale or bpc-157 peptides for sale is shopping in a market with no product standard, which means the listing itself is the only document you get before you pay. Read it accordingly.
| Format | What it is | What you can still verify | Worth buying |
|---|---|---|---|
| Lyophilized 10 mg vial | Freeze-dried powder, sealed under a crimped cap, with a batch number. | Everything: batch, certificate, purity method, net peptide content. | Yes, this is the standard research presentation. |
| Two-peptide blend | BPC-157 combined with another compound in one vial, such as TB-500. | Batch and certificate, if the listing states both masses. | Only if you wanted the second compound too. |
| Multi-peptide blend | Three or more peptides, sold on a total milligram figure. | Little, unless every component mass is published. | Not for comparing BPC-157 value. |
| Pre-mixed solution | Already reconstituted, in a vial or a pre-filled syringe. | Almost nothing about handling, diluent or stability. | No. |
| Oral capsule or nasal spray | Usually a salt form, sold on a delivery claim. | Contents at best; the delivery claim itself is unverified. | No, the claim is the product. |
The formats you will meet searching bpc 157 for sale, and what each one costs you in verifiability.
Lyophilized vials, and what the label has to say
A sealed glass vial of freeze-dried powder under a crimped cap is the format research supply actually uses, and it is the one to default to. Lyophilized peptide is dry, which is why it ships and stores as well as it does, and a dry vial can carry a batch number that ties it to a certificate. Nothing else on this list can do that as cleanly.
Four things belong on the label: the compound name, the mass in milligrams, a batch or lot identifier, and research use only wording. The batch identifier is the one people skim past and the one that matters, because without it a certificate of analysis is describing some other material. A label that instead carries a dosing schedule is a different signal entirely: a supplier writing injection instructions for an unapproved compound has told you it will publish whatever converts.
One measurement point separates a good certificate from a decorative one. An HPLC purity figure tells you what fraction of the peak area was the target compound. It does not confirm identity, which is what mass spectrometry is for, and it does not tell you net peptide content, which is the actual mass of peptide in the vial once counterions and residual water are excluded. A vendor that reports net peptide content is telling you more than one that reports 99% and stops.
Blends and stacks, where the milligram math breaks
Blends are the fastest way to lose track of what you bought. A vial advertised as 20 mg looks like better value than a 10 mg vial until you notice the 20 mg is split across two compounds, and a four-peptide blend can carry an impressive total mass with very little BPC-157 in it. Total milligrams on the front of a listing is not a measure of BPC-157.
The honest version of a blend states each compound and each mass. Ascension's Wolverine Stack does that: BPC-157 10 mg combined with TB-500 10 mg in one vial, listed at $90.00 and $45.00 with the code. Its $2.25 per milligram figure spans both compounds, so it is not cheaper BPC-157, it is BPC-157 plus a second peptide. That is a good deal only if you independently wanted TB-500. Ascension also sells BPC-157 inside two larger multi-peptide blends, GLOW and KLOW, which are worth knowing about mainly so you do not compare their milligram totals against a single-compound vial.
A blend also removes an option you may want later. Two separate vials can be handled separately in a laboratory setting. A pre-blended vial has made that decision for you at the point of manufacture, and no amount of arithmetic afterwards separates them again.
Pre-mixed solutions, capsules and sprays
A pre-mixed vial or a pre-filled syringe of BPC-157 in solution is the format to be most careful with. Peptides in water are less stable than peptides as dry powder, and a solution that was reconstituted before shipping was reconstituted by someone you cannot audit, in a diluent you cannot identify, on a date you cannot verify, then transported at whatever temperature the carrier felt like. The convenience is real. So is everything it costs you, including the ability to check that the vial you received matches the batch on a certificate.
Oral capsules are the other common presentation, and they usually contain a salt form rather than the peptide sold in vials, marketed on a claim of surviving the stomach better. Treat the claim as unsettled. There is no approved oral BPC-157 product anywhere and we have seen no human bioavailability data that would settle whether an oral dose reaches circulation intact. Nasal sprays run into the same problem from a different direction: a delivery claim with no published human data behind it.
None of these are automatically fraudulent. They are formats where the buyer loses the ability to verify anything, which in a market with no product standard is most of what verification you had.
Pharma grade, research grade, and what a purity number claims
Pharmaceutical grade has no regulatory meaning on a BPC-157 listing. The phrase borrows authority from a compendial system that this compound is not in: there is no USP or NF monograph for BPC-157, so there is no published standard for a batch to conform to, and nobody is auditing a claim of conformity that does not exist. Research grade means only that the seller is describing it as research material, which is a labeling decision rather than a quality tier.
Purity claims deserve the same scrutiny. A number with no laboratory name and no method behind it is marketing copy. A number on a certificate from a named laboratory, tied to the batch on your vial, showing HPLC purity and mass spectrometry identity, is evidence. The gap between those two is not small, and it is visible before you pay.
Sterility is a separate claim again, and one that research listings should not be making at all. A certificate of analysis is not a sterility certificate, and purity is not endotoxin testing. A seller that blurs those together is either careless with words or counting on you not noticing.
| What the listing says | What it actually claims | What to ask for |
|---|---|---|
| Pharmaceutical grade | Nothing enforceable. There is no USP or NF monograph for BPC-157 to conform to. | The certificate, and the laboratory that issued it. |
| 99% purity | A peak area figure, if a real assay produced it at all. | An HPLC chromatogram from a named lab, tied to your batch number. |
| Third-party tested | That testing exists somewhere, not that it covers your vial. | A batch number on the certificate that matches the vial label. |
| Verified identity | Meaningless without a method. | Mass spectrometry confirming the molecular weight, around 1419.5. |
| 20 mg blend | A total mass, not a BPC-157 mass. | Each compound named with its own milligram figure. |
| Sterile or endotoxin free | A claim a research listing should not be making. | Nothing. Treat it as a reason to doubt the rest of the page. |
Claims that appear on listings, and the document that would have to back each one.
What is on sale here, and what it costs
The listing we point readers to is the plain one. Ascension Peptides sells BPC-157 as a 10 mg lyophilized vial at $49.00, which the code PEPTIDEDECK takes to $24.50, or $2.45 per milligram. The Wolverine Stack is $90.00, or $45.00 with the code, and contains BPC-157 10 mg with TB-500 10 mg. Buying three, five or ten vials takes 3%, 5% or 10% off the list price, which is $47.53, $46.55 and $44.10 each, and there is no published documentation that the code stacks with those tiers, so assume it does not until the cart says otherwise. Free shipping starts at $250, well above a single discounted vial.
On documentation, Ascension publishes two third-party certificates for its BPC-157 rather than one: Kovera Labs, batch 12-05260628, and MZ Biolabs, batch 12-01260229. Two laboratories on the same material is uncommon in this market. We are reporting what the vendor publishes and not confirming the analyses ourselves. We also earn a commission if you buy through our links, which we explain on our affiliate disclosure page.
For the full per-milligram breakdown against the quantity tiers, our sibling piece on BPC-157 price does the arithmetic properly. The point here is narrower: compare like formats. A blend against a single-compound vial is not a price comparison, it is a different product.
Why there is no pharmacy version to compare against
Everything above exists because the licensed market does not. BPC-157 has never been approved by the FDA, the EMA or the MHRA for any indication, and it has no USP or NF monograph, so there is no reference product whose label, purity standard and packaging the research market would otherwise have to imitate.
The compounding route people assume exists is unsettled rather than open. The FDA placed BPC-157 in Category 2 in September 2023, removed it from Category 2 in April 2026 after the nominations were withdrawn, and on 23 and 24 July 2026 the Pharmacy Compounding Advisory Committee narrowly recommended it for the 503A bulks list. That recommendation is non-binding, BPC-157 is not listed in 21 CFR 216.23, and no final determination has been issued. Clinics advertise injections anyway, which is covered in our piece on BPC-157 near me.
Two last things that no format changes. The World Anti-Doping Agency prohibits BPC-157 at all times under S0, the class for non-approved substances, so any tested athlete is out regardless of what the vial says; the current prohibited list is worth reading directly. And buying peptides as laboratory material is legal in the United States while selling them for human use is not, which is the whole reason the labeling reads the way it does.